Michelle M. Merrigan

1.2k total citations
16 papers, 946 citations indexed

About

Michelle M. Merrigan is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Michelle M. Merrigan has authored 16 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Michelle M. Merrigan's work include Clostridium difficile and Clostridium perfringens research (15 papers), Microscopic Colitis (10 papers) and Viral gastroenteritis research and epidemiology (9 papers). Michelle M. Merrigan is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (15 papers), Microscopic Colitis (10 papers) and Viral gastroenteritis research and epidemiology (9 papers). Michelle M. Merrigan collaborates with scholars based in United States, United Kingdom and Australia. Michelle M. Merrigan's co-authors include Stuart Johnson, Dale N. Gerding, Susan P. Sambol, Michael Mallozzi, Gayatri Vedantam, Anilrudh A. Venugopal, V. K. Viswanathan, Bryan Roxas, Dale N. Gerding and Kevin J. O’Leary and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Journal of Bacteriology.

In The Last Decade

Michelle M. Merrigan

16 papers receiving 915 citations

Peers

Countries citing papers authored by Michelle M. Merrigan

Since Specialization

Citations

This map shows the geographic impact of Michelle M. Merrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle M. Merrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle M. Merrigan more than expected).

Fields of papers citing papers by Michelle M. Merrigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle M. Merrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle M. Merrigan. The network helps show where Michelle M. Merrigan may publish in the future.

Co-authorship network of co-authors of Michelle M. Merrigan

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle M. Merrigan. A scholar is included among the top collaborators of Michelle M. Merrigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle M. Merrigan. Michelle M. Merrigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	The Relative Role of Toxins A and B in the Virulence of Clotridioides difficile 2020 ·Journal of Clinical Medicine ·Andrew M Skinner, (unknown), Michelle M. Merrigan, Kevin J. O’Leary, Susan P. Sambol, Farida Siddiqui, Lance R. Peterson, Dale N. Gerding, Stuart Johnson	11
2	A Multicenter, Randomized, Open Label, Single- and Multiple-Dose, Dose Finding Study and Open-Label Extension to Assess the Effects of Obeticholic Acid in Pediatric Patients with Biliary Atresia 2016 ·Journal of Hepatology ·Saul J. Karpen, Lise Eliot, (unknown), (unknown), Michelle M. Merrigan, (unknown), Tonya Marmon, Roya Hooshmand-Rad, Leigh MacConell, Д. А. Шапиро	2
3	International typing study of Clostridium difficile 2014 ·Anaerobe ·(unknown), Michelle M. Merrigan, Stuart Johnson, Dale N. Gerding, Thomas V. Riley, Joseph Silva, John Brazier	10
4	Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile 2013 ·PLoS ONE ·Michelle M. Merrigan, Anilrudh A. Venugopal, Jennifer Lising Roxas, (unknown), Michael Mallozzi, (unknown), Dale N. Gerding, V. K. Viswanathan, Gayatri Vedantam	102
5	Hypervirulent Clostridium difficile strains: Adherence, toxin production and sporulation 2010 ·Loyola eCommons (Loyola University Chicago) ·Michelle M. Merrigan	1
6	Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production 2010 ·Journal of Bacteriology ·Michelle M. Merrigan, Anilrudh A. Venugopal, Michael Mallozzi, Bryan Roxas, V. K. Viswanathan, Stuart Johnson, Dale N. Gerding, Gayatri Vedantam	220
7	New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration 2009 ·International Journal of Antimicrobial Agents ·Michelle M. Merrigan, Susan P. Sambol, Stuart Johnson, Dale N. Gerding	52
8	Genotypic and Phenotypic Analysis of Clostridium difficile Correlated with Previous Antibiotic Exposure 2006 ·Microbial Drug Resistance ·Matthew H. Samore, Lata Venkataraman, Paola C. DeGirolami, Michelle M. Merrigan, Stuart Johnson, Dale N. Gerding, Yehuda Carmeli, Stephan Harbarth	11
9	Prevention of FatalClostridium difficile–Associated Disease during Continuous Administration of Clindamycin in Hamsters 2003 ·The Journal of Infectious Diseases ·Michelle M. Merrigan, Susan P. Sambol, Stuart Johnson, Dale N. Gerding	44
10	Susceptibility of hamsters to human pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration 2003 ·Anaerobe ·Michelle M. Merrigan	21
11	International Typing Study of Toxin A-Negative, Toxin B-Positive Clostridium difficile Variants 2003 ·Journal of Clinical Microbiology ·Stuart Johnson, Susan P. Sambol, John Brazier, Michel Delmée, V. Avesani, Michelle M. Merrigan, Dale N. Gerding	63
12	Colonization for the Prevention ofClostridium difficileDisease in Hamsters 2002 ·The Journal of Infectious Diseases ·Susan P. Sambol, Michelle M. Merrigan, (unknown), Stuart Johnson, Dale N. Gerding	135
13	Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay 2001 ·Annals of Internal Medicine ·Stuart Johnson, (unknown), Kevin J. O’Leary, Michelle M. Merrigan, Susan P. Sambol, Lance R. Peterson, Dale N. Gerding	113
14	Infection of Hamsters with Epidemiologically Important Strains ofClostridium difficile 2001 ·The Journal of Infectious Diseases ·Susan P. Sambol, (unknown), Michelle M. Merrigan, Stuart Johnson, Dale N. Gerding	97
15	Toxin Gene Analysis of a Variant Strain of Clostridium difficile That Causes Human Clinical Disease 2000 ·Infection and Immunity ·Susan P. Sambol, Michelle M. Merrigan, David M. Lyerly, Dale N. Gerding, Stuart Johnson	63
16	Restriction Endonuclease (REA) Typing of Clostridium difficile Isolates from South America 1999 ·Anaerobe ·Michelle M. Merrigan, (unknown), Liliana Fernández Canigia, Grazia Greco, (unknown), Dale N. Gerding	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact